Wayne, Pennsylvania, United States SCP Vitalife Partners is the famous VC, which was founded in 2002. The company was established in North America in United States. The main department of described VC is located in the Wayne.
We also calculated 2 valuable employees in our database.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - Israel. Among the most popular fund investment industries, there are Analytics, Machine Learning. Among the various public portfolio startups of the fund, we may underline Ivenix, CanFite BioPharma, Fluidnet The fund has exact preference in a number of founders of portfolio startups. If startup sums 3 or 4 of the founder, the chance for it to be financed is low. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
The real fund results show that this VC is 0 percentage points less often commits exit comparing to other companies. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The higher amount of exits for fund were in 2019. The top activity for fund was in 2013. This SCP Vitalife Partners works on 2 percentage points less the average amount of lead investments comparing to the other organizations.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the SCP Vitalife Partners, startups are often financed by Medica Venture Partners, Rockport Venture Partners, ProSeed Venture Capital Fund. The meaningful sponsors for the fund in investment in the same round are OurCrowd, Medica Venture Partners, Israel Healthcare Ventures. In the next rounds fund is usually obtained by OrbiMed, InterWest Partners, DeNovo Ventures.
Related Funds
Funds with similar focus
| Fund Name | Location |
| AUG Management | - |
| Barunson E&A | Seoul-t'ukpyolsi, South Korea, Yongsan |
| Capital6 Eagle | - |
| First In Ventures | - |
| First Seafront Fund | China, Guangdong, Shenzhen |
| Fond-ICO Global | Community of Madrid, Madrid, Spain |
| Hongfu Ruiying | China, Guangdong, Shenzhen |
| Innovation Norway | Norway, Oslo |
| Mitacs | British Columbia, Canada, Vancouver |
| Moonwhale Ventures | Delaware, Ohio, United States |
| OLMA Private Equity Fund | County Dublin, Dublin, Ireland |
| PALgenesis | New York, New York, United States |
| Pharmaceutical Product Development | North Carolina, United States, Wilmington |
| Pintu Media | Beijing, Beijing, China |
| Quest Ventures Southwest | Arizona, Phoenix, United States |
| WHmall | China, Shanghai |
| WSR Capital | Colorado, Highlands Ranch, United States |
| Yucatan Rock Ventures | California, Saratoga, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
MST Medical Surgery Technologies | $12M | 01 Jul 2015 | Israel, North District, Israel | ||
Regentis Biomaterials | $10M | 14 May 2012 | Israel, North District, Israel | ||
Fluidnet | $25M | 16 Aug 2011 | Amesbury, Massachusetts, United States | ||
Avedro | $25M | 07 Jul 2011 | Massachusetts, United States | ||
Garnet Biotherapeutics | $10M | 03 Feb 2009 | Pennsylvania, United States | ||
| $800K | 17 Dec 2003 | North District |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
MST Medical Surgery Technologies | $12M | 01 Jul 2015 | Israel, North District, Israel | ||
Regentis Biomaterials | $10M | 14 May 2012 | Israel, North District, Israel | ||
Fluidnet | $25M | 16 Aug 2011 | Amesbury, Massachusetts, United States | ||
Avedro | $25M | 07 Jul 2011 | Massachusetts, United States | ||
Garnet Biotherapeutics | $10M | 03 Feb 2009 | Pennsylvania, United States | ||
| $800K | 17 Dec 2003 | North District |
